Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
02/07/2024 | 13:00 | GlobeNewswire Inc. | ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
25/06/2024 | 13:00 | GlobeNewswire Inc. | ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
24/06/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
18/06/2024 | 22:37 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
14/06/2024 | 23:23 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
05/06/2024 | 13:59 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
29/05/2024 | 22:30 | GlobeNewswire Inc. | ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
20/05/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Announces the Launch of Kionex® Suspension | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
10/05/2024 | 13:09 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
10/05/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
01/05/2024 | 22:30 | GlobeNewswire Inc. | ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
18/04/2024 | 22:05 | GlobeNewswire Inc. | ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
09/04/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
04/04/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
03/04/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
27/03/2024 | 11:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
29/02/2024 | 13:22 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
29/02/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
20/02/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
07/02/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
29/01/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
23/01/2024 | 22:13 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
23/01/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
17/01/2024 | 13:45 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
16/01/2024 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
22/11/2023 | 15:26 | GlobeNewswire Inc. | ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
21/11/2023 | 02:58 | Edgar (US Regulatory) | Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
08/11/2023 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
25/10/2023 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET | NASDAQ:ANIP | ANI Pharmaceuticals Inc |
02/10/2023 | 12:50 | GlobeNewswire Inc. | ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares | NASDAQ:ANIP | ANI Pharmaceuticals Inc |